| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 673 | 0 | 0 | 0 | 738 | 0 | 708 | 0 | 0 | 0 |
| Total Income - EUR | 675 | 0 | 0 | 0 | 738 | 0 | 708 | 0 | 0 | 0 |
| Total Expenses - EUR | 1.716 | 708 | 132 | 129 | 21 | 0 | 20 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -1.041 | -708 | -132 | -129 | 716 | 0 | 687 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -1.061 | -708 | -132 | -129 | 694 | 0 | 666 | 0 | 0 | 0 |
| Employees | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Meditradox S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 3.392 | 2.650 | 2.582 | 2.578 | 2.528 | 2.480 | 2.425 | 2.433 | 2.425 | 2.412 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 3.238 | 2.662 | 2.617 | 2.569 | 2.519 | 2.472 | 2.417 | 2.424 | 2.417 | 2.403 |
| Cash | 154 | -12 | -35 | 9 | 9 | 8 | 8 | 8 | 8 | 8 |
| Shareholders Funds | -2.022 | -2.709 | -2.796 | -2.873 | -2.123 | -2.083 | -2.037 | -2.043 | -2.037 | -2.026 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.414 | 5.359 | 5.378 | 5.451 | 4.651 | 4.563 | 4.462 | 4.476 | 4.462 | 4.437 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7430 - 7430" | |||||||||
| CAEN Financial Year |
7430
|
|||||||||
Comments - Meditradox S.r.l.